Tuesday, 17 October 2017

Data Center Rack Power Distribution Unit (PDU) for Reliable Power Management

A power distribution unit (PDU) is the device used to control electrical power runs in a data center. It is equipped with multiple outputs that are designed to distribute electric power. PDUs are specifically used to supply power to networking equipment and computer racks within data centers. Power management and protection is a key challenge for data centers. PDUs can assist in monitoring and improving their efficiency. They can also prevent equipment failure. 

Deep Dive into Rack Mounted PDUs

These PDUs can be mounted to an equipment rack to control and monitor the power supply to switches, specific servers, and other components. The four fundamental types of rack PDUs are: 
  • Basic PDUs: Offer consistent power supply and are commonly available in different mounting types and densities
  • Metered PDU: Designed with reliable circuit board and digital display that shows voltage, current, and power levels
  • Intelligent PDU: Combination of metered PDU with remote monitoring and controls
  • Switch PDU: Capable of remotely controlling each outlet
Intelligent Power Distribution Units

Recently, companies like Siemon and Chatsworth Products have introduced intelligent PDUs for data centers. They can be used as stand-alone units or can be paired with third-party software. APC Corporation’s Switched Rack PDUs provide advanced personalized power controls and dynamic monitoring. Their remote outlet level controls comprise power on/off functionality that can limit unauthorised usage through remote rebooting. Users can also configure, access, and control these PDUs over secure web, command. The new AP8000 series Switched Rack PDUs have features like temperature/humidity sensors, real power monitoring, and IEC receptacle locks.

Market Overview

According to a report by Grand View Research, Inc.; the global Data Center Rack Power Distribution Unit (PDU) Market is predicted to gain nearly USD 2.04 billion by 2025. Increasing number of new data centers and requirement of efficient power management can drive the market during the forecast period (2014 to 2025). 

Intelligent PDUs can reduce power wastage in data centers. The segment is expected to generate revenue greater than USD 400 million by 2025. North America is expected to dominate the market with over 4% CAGR till 2025. Asia Pacific is anticipated to witness extensive growth in the near future. High adoption of cloud services is the key regional driver 

Some of the prominent players operating in the worldwide market are APC Corporation; Raritan Inc.; Cyber Power Systems, and Server Technology.

Revenue Cycle Management: The Smart Billing Technology

Healthcare providers require to maintain a balance between care-based models and traditional revenue cycle management. This has brought with it radical changes in terms of trends such as digitization, automation, and centralization of healthcare management and workflow. Rapid increase in the speed of billing cycle, financial challenges, and expansion of the healthcare industry have contributed to the demand for revenue cycle management (RCM) solutions.

Understanding RCM

RCM or revenue cycle management is a financial process that uses medical billing software to keep a track of patient care, right from appointment scheduling and registration to final payments and settlements. RCM is designed and extensively used by healthcare facilities, namely physician offices, diagnostic laboratories, hospitals, etc. 

Noteworthy Recognition

Aprima Medical Software, a Texas, U.S.-based company, introduced the Aprima RCM platform, which merges smart technology with billing expertise. The system assists practices in eligibility check, claims editing, and optimizing costs and collection with the help of better denial management. 

The company’s software and services help find likely coding oversights in billing equipment used, notifies the practice of any amendments in regulations, and compares contacts to spot any possible underpayments, which could affect the growth of the practice. The platform also improves the firm’s financial performance. 

It also includes CMS Medically Necessary Rules, prepayment audits, and ICD-10 coding, increases reimbursements, and helps the practice adhere to objectives of the physician quality reporting system (PQRS).

Market Insight

According to a new report by Grand View Research, Inc., the revenue cycle management (RCM) market is expected to reach USD 65.2 billion by 2025. Need to improve patient care, reduce diagnostic costs, and decrease machine downtime can drive the revenue cycle management market.

Some major competitors in the revenue cycle management market are Allscripts, CareCloud Corporation, The SSI Group, LLC, and NextGen Healthcare Information Solution LLC.

To get free sample report at:

Pressure Monitoring to become More Convenient with Non-invasive Devices

Increasing pressure instabilities in vital parts of the body frequently lead to chronic conditions such as cardiac disorders, respiratory disorders, and glaucoma. This has led to high demand for pressure monitoring devices. 

Unhealthy lifestyle may result in high prevalence of cardiac disease. Hypertension is commonly observed among people with history of cardiac disorders, with high BP being the most common symptom. Therefore, BP monitoring devices exhibit high demand among these patients. 

Low level of oxygen in the blood may lead to problems such as increased shortness of breath and pulse rate and oxygen monitoring devices are highly required to monitor a patient’s oxygen level in the blood. 

Intracranial Pressure (ICP) monitoring plays an important role in diagnosing pressure related to the nervous system and blood vessel tissues to evade any harm to the brain. 

Glaucoma can be detected by determining eye pressure. Intraocular pressure (IOP) monitors are helpful to check IOP, which can change due to several factors such as a patient’s respiration and heart rate. 

Invasive Vs Non-invasive Blood Pressure Monitoring

Invasive Blood Pressure (IBP) monitoring or intra-arterial blood pressure monitoring is usually used in Intensive Care Units (ICU) and operating rooms. This technique includes direct arterial pressure measurement by inserting a cannula needle in the appropriate artery. This is connected to a sterile system filled with fluid, which is linked to an electronic patient monitor system. A patient’s blood pressure is observed beat by beat, displaying a waveform.

Non-invasive measurement methods are generally used for routine check-ups and monitoring. Non-invasive oscillometric and auscultatory methods are easier and faster than invasive measurements, need less proficiency in fitting, and are less painful for patients. However, non-invasive measures may have comparatively lower accuracy and may present minor variances in numerical results. 

Recently, Philips Healthcare developed a health watch that helps track heart rate and other metrics related to cardiac conditions and activities, even while sleeping. Users can obtain personalized information and guidance with the Philips Health Suite health app. Other products such as wrist and arm blood pressure monitors are also helpful for measuring blood pressure and heart rate. These systems are connected to the health app.

Market Overview

According to a report by Grand View Research, Inc., the global pressure monitoring market is predicted to value USD 11.9 billion by 2025. Blood pressure monitoring devices dominated the market in 2016 due to increasing prevalence of cardiac disorders and hypertension. In 2016, North America dominated the market. Asia Pacific is anticipated to exhibit lucrative growth during the forecast period (2014 to 2025) due to rising geriatric population in China.

Key players operating in the market include Medtronic, Philips Healthcare, GE Healthcare, Becton, and Welch Allyn.

To get free sample report at:

Flexible Offshore Mooring Systems Ensuring Optimization of Operations

Anchors hold ships and floating vessels stationed in deep waters. These vessels are confined from the movement of the water thanks to the mooring system, making this system an integral part of subsea production facilities. This system includes anchors, mooring line, and connectors. The mooring lines hold the anchor base on the sea or ocean floor, preventing the vessel from floating away.

Noah-FPSO Hull Supports Flexibility in Design

In April 2017, Mitsui Engineers & Shipbuilding Co., Ltd. was presented with the Bureau Veritas Approval in Principle (AIP) approval for “noah-FPSO Hull” and connected construction technique and design, in compliance with the American Bureau of Shipping. 

“New Offshore Adapted Hull” or “Noah” is an up-gradation of the conventional Floating Production, Storage, and Offloading (FPSO). The noah-FPSO allows a customizable approach to construction and design based on production needs, as compared to making changes in production facilities to suit the hull’s design.

The Noah-FPSO Hull brings with it unique features; for instance, the hull is compatible with other operational fields as a platform. This allows optimization of operations, maintenance, and the Engineering Procurement Construction and Installation (EPCI) process. This modular design is also compatible with a wide range of field requirements and this supports flexibility in design changes, which is common in FPSO endeavors. 

The hull has a wider deck, allowing the installation of heavier and complex topsides. It is made of 2-dimentional bending plates, which reduces construction costs and improves operability against green water or slamming loading. The steady aft/fore and parallel-body module with adjustable length can be manufactured at various shipyards. 

Mitsui has also launched “noah-Alliance” to provide speedy solutions for any challenges that can occur in these initiatives. This system will join any shipyard, globally, to construct the hulls with the help of the company’s services.

Market Insights

The offshore mooring systems market is projected to value USD 1.32 billion by 2025, according to a new study by Grand View Research, Inc. Rise in development of high-temperature gas hydrate basins can drive the market.

Mampaey Offshore Industries B.V., Single Point Mooring Systems, Offspring International, and ScanaIndustrier ASA. are key players in this market. These players provide components, system design, technology services, and planning to offshore oil and gas industries.

Monday, 16 October 2017

Electrodes for Medical Devices to Assure Accurate Diagnosis

An electrode is a solid electric conductor through which electric current enters or leaves an electrolytic cell, other medium, or the non-metallic part of a circuit. Electrodes used in medical devices convert ionic potential into electric signals and are generally made up of metal, lead, or gel. 

How They Work

The electrode used in medical devices transfers ionic current in the body and allows surface quantification of currents, which are amplified to diagnose several nervous, muscular, and cardiac disorders. 

Surface electrodes are aids to find bioelectric abilities from the surface of the body. For example, an electrocardiography (EEG) evaluates electric activity of the heart and needs 12 to 15 surface electrodes for diagnosis. 

Needle electrodes are inserted into the body to get localized measurement of potentials from a specific muscle. For example, an electromyography (EMG) uses a needle electrode to assesses muscular response to electrical activity of a specific muscle. 

Microelectrodes consist of small tips that can be penetrated through a single cell to take readings. 

Wireless Monitoring Pacemaker

Recently, Boston Scientific Corporation developed the “ESSENTIO MRI” and “ACCOLADE MRI” pacemakers, integrated with LATITUDE NXT patient management system. These provide wireless remote monitoring for speedier detection and intervention and improved patient outcomes. The Atrial Arrhythmia Report can be accessed using these pacemakers, which provides a complete view of the AT/AF status of a patient and any other information required for assessing the efficacy of AF treatment. 

A recent clinical study on the use of Remote Monitoring (RM) technology within cardiac rhythm devices exhibited that patients not under remote observation are at greater risk of mortality than those frequently tracked with automatic daily monitoring. 

Market Overview

Increasing prevalence of heart diseases and neurological disorders has resulted in extensive use of ECG and EEG devices, thereby driving demand for electrodes. According to a report by Grand View Research, Inc., the global electrodes for medical devices market is predicted to gain nearly USD 2.0 billion by 2025. 

North America is anticipated to dominate the market during the forecast period (2014 to 2025) due to increasing prevalence of CVDs. Prominent players in the market include GE Healthcare, 3M Healthcare, Boston Scientific Corporation, Medtronic, and Philips Healthcare.

To get free sample report at:

Improving Access to Healthcare Facilities to Benefit Uptake of Structural Heart Devices

Structural heart disease (SHD) is an umbrella term for various defects or abnormalities of the heart. This may include structural anomalies, functional abnormalities, congenital heart diseases, and acquired heart diseases. It was found that nearly 20% to 25%, or roughly 60 million, people in the U.S. have been diagnosed with SHD. 

An SHD is a non-coronary heart defect; this means that the disease does not affect blood vessels. The condition is often congenital, meaning that it is present since the time of birth. However, this defect can also be acquired later in life, caused due to wear and tear by infections. 

Boston Scientific Launches Permanent Implant Delivery Catheters  

The U.S. FDA recently approved an innovative technology called “Watchman LAA Closure Technology”, introduced by Boston Scientific. Watchman is a closure technology used as permanent implant delivery catheters. This helps avert Left Atrial Appendage (LAA) blood clots from entering the blood stream, causing strokes. The catheters have a self-inflating Nitinol or nickel-titanium frame. This frame has a woven plastic cap attached to it. 

The delivery catheter is inserted into a vein in the patient’s leg. Through the bloodstream, the catheter reaches the right atrium or the upper right heart chamber. A tiny incision is made in the wall between the two heart chambers. This incision allows the catheter to reach its destination – the LAA. 

The catheter is then pushed into the LAA, where it opens like an umbrella and is permanently fixed there. In around 45 days, a thin layer of tissue grows over the implant, preventing blood clot(s) from entering the bloodstream. This innovative device can be a boon for patients suffering from atrial fibrillation (AFib).

Market Insight

The global structural heart devices market can reach USD 9.1 billion by 2025, according to a new research by Grand View Research, Inc. The market is anticipated to grow at a 9.15% CAGR over the forecast period (2014 and 2025). Greater awareness, rigid screening, access to treatment, and support from governments across the globe can drive the market over the coming years. 

Key companies in the structural heart devices market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, and St. Jude Medical. These companies are often involved in mergers and acquisitions and developing new and innovative products to improve and strengthen their portfolio.

In-depth research report on structural heart devices market:

Friday, 13 October 2017

Blood Culture Tests become Quicker and More Accurate with Automated Techniques

Generally, blood does not contain any kind of bacteria or fungi. A blood culture test detects existence of bacteria, fungi, or microbiological infection in the blood. It is useful for treating several bacterial infections that spread into the blood in several circumstances such as osteomyelitis, meningitis, pneumonia, kidney infection, and sepsis.

Conventional Techniques Vs Automated Technologies

Standard blood culture bottles comprise one holding aerobic culture media and the other containing anaerobic media. Usually at least 10-15 mL of blood specimen should be collected using venepuncture and injected into blood culture bottles. For maximizing diagnostic yields of blood cultures, multiple sets of cultures may be taken by healthcare specialists. 

BioMérieux is a world leader in microbiology and considered to be a major player in in vitro diagnostics. The company has developed BacT/ALERT VIRTUO, which is a completely automatic blood culture system. It is easy to use and operates with load-and-go technology. The uploading of bottles is fully automated with visual and addible alarms. It offers powerful exclusive algorithms, high thermal stability, and superior optics, which increase performance and translate into faster detection of bloodstream infections.

Market Overview

According to Grand View Research, Inc., increasing frequency of bloodstream infections and infectious diseases is the most important aspect predicted to propel growth of the blood culture test market over the forecast period. The market value is estimated to reach USD 6.6 billion by 2025. Demand for advanced techniques to diagnose infectious diseases and conditions like sepsis is another key driving factor. Automated blood culture systems are predicted to form the fastest growing segment due to the accuracy and efficiency they offer. Reference laboratories are anticipated to grow rapidly due to outsourcing of blood tests by hospitals. 

With well-developed infrastructure, North America is the leading regional market and accounted for the largest market share in 2016. Asia Pacific is estimated to grow at the highest CAGR during the forecast period due to high incidence of infectious diseases and presence of refining healthcare and R&D infrastructures. 

Some of the major players operating in the blood culture test market are Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.; bioMérieux SA; Danaher Corporation; Roche Diagnostics; and Bruker Corporation.

To get free sample request at: